At a glance
ClinicalIndex Comparison RecordN/ACompleted· 91 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Mobile Medical Application for Cost-effective Strabismus Screening
In Brief
An observational study for Strabismus. Completed, enrolled 91 participants across 1 site.
Detailed Summary
Develop and evaluate a new smartphone based app to screen for and measure eye misalignment (strabismus). The investigators will validate the app against simulated strabismus of known magnitude and common clinical tests. They will evaluate the app as a screening tool in high risk populations, to determine the sensitivity and specificity. They hypothesize that the app can measure to within 2 units (prism diopters) of the ground truth, and that it will be correlated with gold standard tests.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsStrabismus
CountriesUnited States
CollaboratorsNational Eye Institute (NEI)
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
Enrollment StartFeb 2018
First PostedMar 2018
Primary CompletionDec 2019
Study CompletionJan 2025
TodayJul 2026
First PostedMar 1, 2018
Enrollment StartFeb 1, 2018
Primary CompletionDec 30, 2019
Study CompletionJan 30, 2025
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 8.3 years ago